PARAMETRIC PORTFOLIO ASSOCIATES LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 88 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$5,443,000
-42.6%
118,346
-17.3%
0.00%
-40.0%
Q4 2021$9,490,000
+20.7%
143,144
+13.6%
0.01%
+25.0%
Q3 2021$7,865,000
-26.8%
125,980
-2.9%
0.00%
-33.3%
Q2 2021$10,749,000
+47.5%
129,791
+18.1%
0.01%
+50.0%
Q1 2021$7,285,000
-27.2%
109,868
-15.8%
0.00%
-33.3%
Q4 2020$10,012,000
+143.6%
130,485
+36.7%
0.01%
+100.0%
Q3 2020$4,110,000
-17.9%
95,441
-17.7%
0.00%
-25.0%
Q2 2020$5,006,000
+85.8%
115,901
+23.8%
0.00%
+100.0%
Q1 2020$2,694,000
-68.6%
93,654
-30.8%
0.00%
-66.7%
Q4 2019$8,586,000
+103.3%
135,356
-9.7%
0.01%
+100.0%
Q3 2019$4,223,000
+98.4%
149,856
+86.6%
0.00%
+50.0%
Q2 2019$2,128,000
+131.3%
80,302
+60.1%
0.00%
+100.0%
Q1 2019$920,000
+43.3%
50,155
-2.9%
0.00%0.0%
Q4 2018$642,000
-36.2%
51,656
-1.7%
0.00%0.0%
Q3 2018$1,007,000
+2861.8%
52,536
+184.5%
0.00%
Q1 2017$34,000
-87.2%
18,468
-48.7%
0.00%
Q3 2016$265,000
+258.1%
36,002
+157.8%
0.00%
Q2 2016$74,00013,9670.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2016
NameSharesValueWeighting ↓
ELEMENT CAPITAL MANAGEMENT LLC 142,649$618,0000.25%
ING GROEP NV 808,229$3,500,0000.07%
A.R.T. Advisors, LLC 232,470$1,006,0000.05%
OppenheimerFunds, Inc. 3,000,000$12,990,0000.02%
Edge Wealth Management LLC 10,000$43,0000.01%
First Allied Advisory Services, Inc. 61,000$264,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$866,0000.01%
MILLENNIUM MANAGEMENT LLC 1,272,138$5,508,0000.01%
D. E. Shaw & Co., Inc. 971,768$4,208,0000.01%
Virtu Financial LLC 18,008$78,0000.00%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders